Published date: 5 July 2023

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 31 July 2023, 3pm

Contract summary

Industry

  • Construction work for research buildings - 45214600

  • Construction work for manufacturing plant - 45254200

  • Feasibility study, advisory service, analysis - 71241000

    • Construction consultancy services - 71530000

Location of contract

South East

Value of contract

£50,000 to £100,000

Procurement reference

BIP793438831

Published date

5 July 2023

Closing date

31 July 2023

Closing time

3pm

Contract start date

1 September 2023

Contract end date

30 September 2023

Contract type

Service contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NATA intends to build a case to design and construct a 'fit for purpose' oligonucleotide cGMP facility in the UK and, as a first step, the aim of this exercise is to scope that facility from the perspectives of cost, timelines and operations, and to build details around those criteria.

More information

Links

Additional text

The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.

About the buyer

Contact name

Commercial Business Partner

Address

Medical Research Council
Polaris House
Swindon
SN2 1FL
UK

Telephone

+441793867000

Email

mrcprocurement@ukri.org